May 26, 2023 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q4 FY '23 Earnings Conference Call of Sun Pharmaceuticals Industries Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Dr. Abhishek Sharma, Head of Investor Relations. Thank you, and over to you, sir.
Abhishek Sharma -
Thank you. Good evening, and a warm welcome to our fourth quarter FY '23 earnings call. I am Abhishek Sharma from the Sun Pharma Investor Relations team. We hope you have received the Q4 financials and the press release that was sent out earlier in the day. These are also available on our website. We have with us Mr. Dilip Shanghvi, Managing Director; Mr. C. S. Muralidharan, CFO; Mr. Abhay Gandhi, CEO, North America; and Mr. Kirti Ganorkar, CEO, India business. Today, the team will focus -- team will discuss financial performance for the quarter, business highlights and respond to any questions that you may have. For ease of discussion, we will look at consolidation -- consolidated financials. The call recording and call
Full Year 2023 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
May 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers